Showing results (81-90 of 522) with videos related to
Sort By:
Pageof 53
The Pediatric Infectious Disease Journal|March 1, 1988
Evaluation of an intervention program for head lice infestation in school childrenB Sarov, L Neumann, Y Herman, et al.Antimicrobial Agents and Chemotherapy|August 1, 1996
Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureusE Y Ng, M Trucksis, D C HooperCurrent Molecular Medicine|August 22, 2006
Cardiac biomarkers for the prediction and diagnosis of atherosclerotic disease and its complicationsM D Weinberg, W C Hooper, G DangasSeminars in Ophthalmology|June 28, 2008
Who (what) pays toll for the development of herpetic stromal keratitis (HSK)Kozaburo Hayashi, Laura C Hooper, John J HooksJournal of Bacteriology|September 1, 1991
A novel locus conferring fluoroquinolone resistance in Staphylococcus aureusM Trucksis, J S Wolfson, D C HooperPsychopharmacology Bulletin|January 1, 1994
Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorderD Bakish, A Ravindran, C Hooper, et al.Medicine|August 26, 1998
Nocardia bacteremia. Report of 4 cases and review of the literatureD P Kontoyiannis, K Ruoff, D C HooperEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1992
Synergism of trimethoprim and ciprofloxacin in vitro against clinical bacterial isolatesP Huovinen, J S Wolfson, D C HooperJournal of Bacteriology|February 15, 2002
NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomesJian-Lin Yu, Leo Grinius, David C HooperInternational Journal of Antimicrobial Agents|January 24, 2018
Chromosomal mutations that accompany qnr in clinical isolates of Escherichia coliLaura Vinué, David C Hooper, George A JacobyPageof 53